Integrated Advisors Network’s Bristol-Myers Squibb BMY Stock Holding History

Integrated Advisors Network’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.18M	Buy	18,905 +1,308	+7%	+$82.7K	0.05%	292
2026 Q2	$1.01M	Sell	17,597 -3,834	-18%	-$220K	0.05%	317
2026 Q1	$1.3M	Sell	21,431 -3,592	-14%	-$209K	0.07%	276
2025 Q4	$1.35M	Buy	25,023 +1,219	+5%	+$58.6K	0.06%	295
2025 Q3	$1.07M	Buy	23,804 +3,517	+17%	+$164K	0.05%	350
2025 Q2	$939K	Sell	20,287 -126	-0.6%	-$6.18K	0.04%	369
2025 Q1	$1.24M	Buy	20,413 +3,025	+17%	+$176K	0.06%	284
2024 Q4	$983K	Sell	17,388 -1,550	-8%	-$86.6K	0.05%	309
2024 Q3	$980K	Sell	18,938 -5,434	-22%	-$255K	0.05%	322
2024 Q2	$1.01M	Sell	24,372 -72,855	-75%	-$3.26M	0.05%	304
2024 Q1	$5.27M	Buy	97,227 +65,448	+206%	+$3.33M	0.27%	96
2023 Q4	$1.63M	Sell	31,779 -6,160	-16%	-$323K	0.09%	222
2023 Q3	$2.2M	Sell	37,939 -5,942	-14%	-$364K	0.13%	182
2023 Q2	$2.81M	Sell	43,881 -55,556	-56%	-$3.73M	0.16%	162
2023 Q1	$6.89M	Buy	99,437 +47,577	+92%	+$3.36M	0.41%	53
2022 Q4	$3.73M	Buy	51,860 +1,101	+2%	+$83K	0.24%	123
2022 Q3	$3.61M	Sell	50,759 -2,100	-4%	-$152K	0.25%	107
2022 Q2	$4.07M	Sell	52,859 -56,888	-52%	-$4.33M	0.26%	109
2022 Q1	$8.02M	Buy	109,747 +16,776	+18%	+$1.13M	0.47%	46
2021 Q4	$5.8M	Buy	92,971 +8,043	+9%	+$472K	0.34%	67
2021 Q3	$5.02M	Buy	84,928 +49,168	+137%	+$3.24M	0.33%	65
2021 Q2	$2.39M	Sell	35,760 -40,976	-53%	-$2.67M	0.18%	146
2021 Q1	$4.84M	Buy	76,736 +5,921	+8%	+$368K	0.44%	54
2020 Q4	$4.39M	Buy	70,815 +171	+0.2%	+$10.5K	0.48%	45
2020 Q3	$4.26M	Sell	70,644 -4,339	-6%	-$261K	0.54%	47
2020 Q2	$4.41M	Buy	74,983 +1,498	+2%	+$89.6K	0.52%	41
2020 Q1	$4.1M	Buy	73,485 +3,248	+5%	+$199K	0.8%	29
2019 Q4	$4.51M	Buy	+70,237	New	+$4.02M	0.61%	37

Other funds holding BMY

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Integrated Advisors Network's BMY Position: Q3 2026 in Review

Integrated Advisors Network increased its Bristol-Myers Squibb (BMY) stake by 7.4% in Q3 2026, buying an estimated $82.7K and bringing the position to 18,905 shares worth $1.18M. The position accounts for 0.05% of the portfolio, ranked #292.

Integrated Advisors Network first reported a position in BMY in Q4 2019 and has held it in 28 quarters since. The position peaked at $8.02M in Q1 2022. 1,763 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

Integrated Advisors Network held 18,905 shares of Bristol-Myers Squibb worth $1.18M as of Q3 2026.
Integrated Advisors Network bought 1,308 Bristol-Myers Squibb shares in Q3 2026, an estimated $82.7K.
Bristol-Myers Squibb made up 0.05% of Integrated Advisors Network's portfolio in Q3 2026, its #292 holding.
Integrated Advisors Network first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 28 quarters since.
Integrated Advisors Network's Bristol-Myers Squibb position peaked at $8.02M in Q1 2022.
1,763 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Integrated Advisors Network's 13F filing for Q3 2026, filed 20 Oct 2026.